Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Dec 2;311(7018):1468–1471. doi: 10.1136/bmj.311.7018.1468

Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. AIDS in Europe Study Group.

T V Perneger 1, P Sudre 1, J D Lundgren 1, B Hirschel 1
PMCID: PMC2543714  PMID: 8520334

Abstract

OBJECTIVE--To assess the impact of tuberculosis on mortality in patients with AIDS. DESIGN--Community based cohort study. SETTING--52 centres in 17 countries (AIDS in Europe study). SUBJECTS--5249 patients who were alive and free of tuberculosis one month after the diagnosis of AIDS, enrolled between 1979 and 1989, and followed up until 1992. MAIN OUTCOME MEASURES--Onset of clinically active tuberculosis or death, or both. RESULTS--During a mean follow up period of 15 months 201 (4%) patients developed tuberculosis and 3889 (74%) died. Patients who developed tuberculosis survived significantly longer (median 22 months) than those who did not (median 16 months). This apparent survival advantage was due to patients who survived longer having more opportunity to develop tuberculosis (or any other disease). In models that took into account the time at which tuberculosis was diagnosed, the onset of tuberculosis was associated with a significant increase in mortality (adjusted relative hazard of death 1.34; 95% confidence interval 1.12 to 1.60). CONCLUSIONS--The onset of tuberculosis in patients with AIDS predicts a substantial increase in mortality. Whether this increased mortality is directly attributable to the tuberculosis remains uncertain. If the association is causal preventive chemotherapy and aggressive treatment of tuberculosis could improve survival in AIDS.

Full text

PDF
1468

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackah A. N., Coulibaly D., Digbeu H., Diallo K., Vetter K. M., Coulibaly I. M., Greenberg A. E., De Cock K. M. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet. 1995 Mar 11;345(8950):607–610. doi: 10.1016/s0140-6736(95)90519-7. [DOI] [PubMed] [Google Scholar]
  2. Braun M. M., Coté T. R., Rabkin C. S. Trends in death with tuberculosis during the AIDS era. JAMA. 1993 Jun 9;269(22):2865–2868. [PubMed] [Google Scholar]
  3. Brudney K., Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991 Oct;144(4):745–749. doi: 10.1164/ajrccm/144.4.745. [DOI] [PubMed] [Google Scholar]
  4. Buira E., Gatell J. M., Miró J. M., Batalla J., Zamora L., Mallolas J., Aznar E., Soriano E., San Miguel J. G. Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients. J Acquir Immune Defic Syndr. 1992;5(7):737–742. [PubMed] [Google Scholar]
  5. Busillo C. P., Lessnau K. D., Sanjana V., Soumakis S., Davidson M., Mullen M. P., Talavera W. Multidrug resistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. Chest. 1992 Sep;102(3):797–801. doi: 10.1378/chest.102.3.797. [DOI] [PubMed] [Google Scholar]
  6. Chaisson R. E., Schecter G. F., Theuer C. P., Rutherford G. W., Echenberg D. F., Hopewell P. C. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis. 1987 Sep;136(3):570–574. doi: 10.1164/ajrccm/136.3.570. [DOI] [PubMed] [Google Scholar]
  7. Chequer P., Hearst N., Hudes E. S., Castilho E., Rutherford G., Loures L., Rodrigues L. Determinants of survival in adult Brazilian AIDS patients, 1982-1989. The Brazilian State AIDS Program Co-Ordinators. AIDS. 1992 May;6(5):483–487. [PubMed] [Google Scholar]
  8. De Cock K. M., Grant A., Porter J. D. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice. Lancet. 1995 Apr 1;345(8953):833–836. doi: 10.1016/s0140-6736(95)92967-3. [DOI] [PubMed] [Google Scholar]
  9. Horsburgh C. R., Jr, Pozniak A. Epidemiology of tuberculosis in the era of HIV. AIDS. 1993;7 (Suppl 1):S109–S114. [PubMed] [Google Scholar]
  10. Lundgren J. D., Pedersen C., Clumeck N., Gatell J. M., Johnson A. M., Ledergerber B., Vella S., Phillips A., Nielsen J. O. Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ. 1994 Apr 23;308(6936):1068–1073. doi: 10.1136/bmj.308.6936.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Small P. M., Schecter G. F., Goodman P. C., Sande M. A., Chaisson R. E., Hopewell P. C. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991 Jan 31;324(5):289–294. doi: 10.1056/NEJM199101313240503. [DOI] [PubMed] [Google Scholar]
  12. Whalen C., Horsburgh C. R., Hom D., Lahart C., Simberkoff M., Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med. 1995 Jan;151(1):129–135. doi: 10.1164/ajrccm.151.1.7812542. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES